RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+15.79%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$280M
AUM Growth
–
Cap. Flow
+$280M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
44.86%
Holding
69
New
69
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$21.4M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$20.5M |
| 3 |
Biogen
BIIB
|
$14.8M |
| 4 |
AbbVie
ABBV
|
$11.9M |
| 5 |
CELG
Celgene Corp
CELG
|
$10.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 72.98% |
| 2 | Financials | 1.53% |
| 3 | Industrials | 0.94% |
| 4 | Technology | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTWR
26
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $3.08M | 1.1% |
+32,750
| New | +$3.08M |
|
|
OREX
27
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.96M | 1.06% |
+52,500
| New | +$2.96M |
|
28
Pacira BioSciences
PCRX
$1.19B
| $2.9M | 1.04% |
+50,500
| New | +$2.9M |
|
29
Edwards Lifesciences
EW
$47.7B
| $2.8M | 1% |
+255,000
| New | +$2.8M |
|
|
AEGR
30
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $2.79M | 1% |
+39,250
| New | +$2.79M |
|
31
HCA Healthcare
HCA
$98.2B
| $2.77M | 0.99% |
+58,000
| New | +$2.77M |
|
|
ATHN
32
DELISTED
Athenahealth, Inc.
ATHN
| $2.62M | 0.94% |
+19,500
| New | +$2.62M |
|
|
TRNX
33
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.44M | 0.87% |
+130,000
| New | +$2.44M |
|
34
Universal Health Services
UHS
$12.1B
| $2.32M | 0.83% |
+28,500
| New | +$2.32M |
|
35
Innoviva
INVA
$1.29B
| $2.25M | 0.8% |
+78,183
| New | +$2.25M |
|
|
CVD
36
DELISTED
COVANCE INC.
CVD
| $2.25M | 0.8% |
+25,500
| New | +$2.25M |
|
|
FEIC
37
DELISTED
FEI COMPANY
FEIC
| $2.19M | 0.78% |
+24,500
| New | +$2.19M |
|
38
Incyte
INCY
$16.9B
| $2.1M | 0.75% |
+41,500
| New | +$2.1M |
|
|
AUXL
39
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $2.07M | 0.74% |
+100,000
| New | +$2.07M |
|
40
Cooper Companies
COO
$13.6B
| $2.04M | 0.73% |
+66,000
| New | +$2.04M |
|
|
FRX
41
DELISTED
FOREST LABORATORIES INC
FRX
| $2.04M | 0.73% |
+34,000
| New | +$2.04M |
|
|
PCYC
42
DELISTED
PHARMACYCLICS INC
PCYC
| $1.96M | 0.7% |
+18,500
| New | +$1.96M |
|
|
CERN
43
DELISTED
Cerner Corp
CERN
| $1.9M | 0.68% |
+34,000
| New | +$1.9M |
|
|
ITMN
44
DELISTED
INTERMUNE INC
ITMN
| $1.84M | 0.66% |
+125,000
| New | +$1.84M |
|
45
Pediatrix Medical
MD
$1.48B
| $1.71M | 0.61% |
+32,000
| New | +$1.71M |
|
46
Jazz Pharmaceuticals
JAZZ
$7.89B
| $1.65M | 0.59% |
+13,000
| New | +$1.65M |
|
|
TSRO
47
DELISTED
TESARO, Inc.
TSRO
| $1.65M | 0.59% |
+58,250
| New | +$1.65M |
|
48
Viatris
VTRS
$12.2B
| $1.58M | 0.57% |
+36,500
| New | +$1.58M |
|
49
Cencora
COR
$56.7B
| $1.58M | 0.57% |
+22,500
| New | +$1.58M |
|
|
ABCO
50
DELISTED
Advisory Board Co/The
ABCO
| $1.56M | 0.56% |
+24,500
| New | +$1.56M |
|